AI molecular diagnostics risk worsening equity gaps without deliberate bias mitigation, expert review warns

An expert review cautions that AI-driven molecular diagnostics may amplify existing healthcare disparities unless demographic biases in training data and algorithms are proactively addressed (exact figures not reported in source).

• Design: Expert narrative review of bias in AI-based molecular diagnostic tools.
• Key concern: Performance can degrade across underrepresented demographic groups, leading to misdiagnosis or unequal access; specific mitigation strategies are proposed.
• Limitation: This is a qualitative expert opinion, not a systematic review with pooled quantitative bias estimates.

RadPigeon summaries are original and for information only. They are not clinical advice.